Exposure to Common Food Additive Carrageenan Alone Leads to Fasting Hyperglycemia and in Combination with High Fat Diet Exacerbates Glucose Intolerance and Hyperlipidemia Without Effect on Weight

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2015 Apr 18

PMID 25883986

Citations 13

Authors

Sumit Bhattacharyya

Leo Feferman

Terry Unterman

Joanne K Tobacman

Affiliations

Soon will be listed here.

Abstract

Aims: Major aims were to determine whether exposure to the commonly used food additive carrageenan could induce fasting hyperglycemia and could increase the effects of a high fat diet on glucose intolerance and dyslipidemia.

Methods: C57BL/6J mice were exposed to either carrageenan, high fat diet, or the combination of high fat diet and carrageenan, or untreated, for one year. Effects on fasting blood glucose, glucose tolerance, lipid parameters, weight, glycogen stores, and inflammation were compared.

Results: Exposure to carrageenan led to glucose intolerance by six days and produced elevated fasting blood glucose by 23 weeks. Effects of carrageenan on glucose tolerance were more severe than from high fat alone. Carrageenan in combination with high fat produced earlier onset of fasting hyperglycemia and higher glucose levels in glucose tolerance tests and exacerbated dyslipidemia. In contrast to high fat, carrageenan did not lead to weight gain. In hyperinsulinemic, euglycemic clamp studies, the carrageenan-exposed mice had higher early glucose levels and lower glucose infusion rate and longer interval to achieve the steady-state.

Conclusions: Carrageenan in the Western diet may contribute to the development of diabetes and the effects of high fat consumption. Carrageenan may be useful as a nonobese model of diabetes in the mouse.

Citing Articles

Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial.

Wagner R, Buettner J, Heni M, Fritsche L, Kullmann S, Wagmuller M BMC Med. 2024; 22(1):558.

PMID: 39593091 PMC: 11590543. DOI: 10.1186/s12916-024-03771-8.

Ultraprocessing and presence of additives in commercially produced complementary foods in seven Southeast Asian countries: a cross-sectional study.

Pries A, Bassetti E, Badham J, Baker P, Blankenship J, Dunford E Am J Clin Nutr. 2024; 120(2):310-319.

PMID: 38816268 PMC: 11347792. DOI: 10.1016/j.ajcnut.2024.04.003.

Encapsulation of Hydrolysate with DPP-IV Inhibitory Activity by Electrospraying and Spray-Drying.

Berraquero-Garcia C, Martinez-Sanchez L, Guadix E, Garcia-Moreno P Nanomaterials (Basel). 2024; 14(10).

PMID: 38786796 PMC: 11123797. DOI: 10.3390/nano14100840.

Common food additive carrageenan inhibits proglucagon expression and GLP-1 secretion by human enteroendocrine L-cells.

Bhattacharyya S, Borthakur A, Tobacman J Nutr Diabetes. 2024; 14(1):28.

PMID: 38755184 PMC: 11099076. DOI: 10.1038/s41387-024-00284-4.

Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective.

Torreggiani M, Fois A, Lippi F, Attini R, Longhitano E, Matarazzo I Clin Kidney J. 2023; 16(4):647-661.

PMID: 37007696 PMC: 10061440. DOI: 10.1093/ckj/sfac267.

References

Williams M, Rutherford S, Feingold K . Effects of cholesterol sulfate on lipid metabolism in cultured human keratinocytes and fibroblasts. J Lipid Res. 1987; 28(8):955-67. View

Tanemura M, Yin D, Chong A, Galili U . Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000; 105(3):301-10. PMC: 377438. DOI: 10.1172/JCI7358. View

Tobacman J . Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect. 2001; 109(10):983-94. PMC: 1242073. DOI: 10.1289/ehp.01109983. View

Epstein Jr E, Krauss R, Shackleton C . X-linked ichthyosis: increased blood cholesterol sulfate and electrophoretic mobility of low-density lipoprotein. Science. 1981; 214(4521):659-60. DOI: 10.1126/science.6945674. View

Elias P, Williams M, Maloney M, Bonifas J, Brown B, Grayson S . Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest. 1984; 74(4):1414-21. PMC: 425309. DOI: 10.1172/JCI111552. View

Potteiger J, Jacobsen D, Donnelly J . A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults. Int J Obes Relat Metab Disord. 2002; 26(1):87-9. DOI: 10.1038/sj.ijo.0801839. View

Teranishi K, Manez R, Awwad M, Cooper D . Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates. Xenotransplantation. 2002; 9(2):148-54. DOI: 10.1034/j.1399-3089.2002.1o058.x. View

Tobacman J, Hinkhouse M, Khalkhali-Ellis Z . Steroid sulfatase activity and expression in mammary myoepithelial cells. J Steroid Biochem Mol Biol. 2002; 81(1):65-8. DOI: 10.1016/s0960-0760(02)00048-1. View

Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon M . Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem. 2002; 277(50):48115-21. DOI: 10.1074/jbc.M209459200. View

10.

Tsuji R, Hoshino K, Noro Y, Tsuji N, Kurokawa T, Masuda T . Suppression of allergic reaction by lambda-carrageenan: toll-like receptor 4/MyD88-dependent and -independent modulation of immunity. Clin Exp Allergy. 2003; 33(2):249-58. DOI: 10.1046/j.1365-2222.2003.01575.x. View

11.

Costa F, Mumolo M, Bellini M, Romano M, Ceccarelli L, Arpe P . Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis. 2003; 35(9):642-7. DOI: 10.1016/s1590-8658(03)00381-5. View

12.

Perseghin G, Petersen K, Shulman G . Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord. 2004; 27 Suppl 3:S6-11. DOI: 10.1038/sj.ijo.0802491. View

13.

Bergner E, Shapiro L . Increased cholesterol sulfate in plasma and red blood cell membranes of steroid sulfatase deficient patients. J Clin Endocrinol Metab. 1981; 53(1):221-3. DOI: 10.1210/jcem-53-1-220. View

14.

Willis T, Jadayel D, Du M, Peng H, Perry A, Price H . Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999; 96(1):35-45. DOI: 10.1016/s0092-8674(00)80957-5. View

15.

Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L . Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet. 1999; 22(1):63-8. DOI: 10.1038/8767. View

16.

Galili U . The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol. 2005; 83(6):674-86. DOI: 10.1111/j.1440-1711.2005.01366.x. View

17.

Mohammad M, Morran M, Slotterbeck B, Leaman D, Sun Y, von Grafenstein H . Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol. 2006; 18(7):1101-13. DOI: 10.1093/intimm/dxl045. View

18.

Song M, Kim K, Yoon J, Kim J . Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun. 2006; 346(3):739-45. DOI: 10.1016/j.bbrc.2006.05.170. View

19.

Shi H, Kokoeva M, Inouye K, Tzameli I, Yin H, Flier J . TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116(11):3015-25. PMC: 1616196. DOI: 10.1172/JCI28898. View

20.

Borthakur A, Bhattacharyya S, Dudeja P, Tobacman J . Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2006; 292(3):G829-38. DOI: 10.1152/ajpgi.00380.2006. View